Fed. Circ. Rulings Crystallize Polymorph Patent 'Obviousness'
The fact that an active pharmaceutical ingredient may exist in more than one crystalline form, i.e., polymorphs, can play a key role in an innovator's patent lifecycle management strategy.[1]...To view the full article, register now.
Already a subscriber? Click here to view full article